• About
• Links
• Contact
• Sitemap

Disposable Syringe Markets

This TriMark Publications report examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor disease and to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth in the U.S. and internationally. Unit and dollar volume are used to indicate market sizes. Additionally, this review examines industry challenges and potential threats to syringe and needle supplies manufacturers and makes strategic recommendations for boosting market share. The emphasis is on those companies actively developing and marketing products to hospitals, physicians and the general public for medically related uses. The disposable syringe market segments are identified as:

1) total reusable needle and syringe market;

2) total disposable needle and syringe market;

3) prefilled syringes;

4) safety syringes;

5) insulin injector pens;

6) needleless injectors;

7) vaccination injectors;

8) blood collection needles and syringes;

9) hypodermic needles and syringes market;

10) insulin needles and syringes market;

11) specialty needles and syringes market; and

12) needleless injector market.

Table of Contents

• 1. Introduction 4
  • 1.1 Statement of Report 4
  • 1.2 About This Report 4
  • 1.3 Scope of the Report 4
  • 1.4 Objectives 5
  • 1.5 Methodology 6
  • 1.6 Executive Summary 6
  
  
• 2. Disposable Syringe Markets 7
  • 2.1 Overview 7
  • 2.2 Infection Control and Safety 9
  • 2.3 Hospital Consolidations Pressure Companies to Reduce Prices 13
  • 2.4 Needleless Injector Manufacturers Forge Strategic Alliances 13
  • 2.5 Technological Advancements in Disposable Syringes 13
  
  
• 3. Syringe Market Segments 16
  • 3.1 Overview 16
    • 3.1.1 World Market 16
    • 3.1.2 U.S. Market 18
  • 3.2 Total Reusable Needle and Syringe Market 18
  • 3.3 Total Disposable Needle and Syringe Market 18
  • 3.4 Prefilled Syringes 21
  • 3.5 Insulin Injector Pens 22
  • 3.6 Needleless Injectors 22
  • 3.7 Vaccination Injectors 23
  • 3.8 Needle and Syringe Market Trends 25
    • 3.8.1 Market Segments 25
    • 3.8.2 Customer Needs 26
    • 3.8.3 Competitor Analysis 26
    • 3.8.4 Target Markets for Specialty Syringes 29
    • 3.8.5 Third-Party Reimbursement 30
    • 3.8.6 Regulation 30
    • 3.8.7 Drug Discovery Trends 30
    • 3.8.8 Demographic Shifts 31
    • 3.8.9 Managed Care Initiatives 31
    • 3.8.10 Growth in Home Healthcare 32
    
    
• 4. Technology Development and Sterilization Methods 34
  • 4.1 Disposable Syringes 34
    • 4.1.1 Autodestruct Syringes 35
    • 4.1.2 SoloShot™ 35
  • 4.2 Monodose Syringes 36
  • 4.3 Prefilled Syringes 36
    • 4.3.1 Features of Prefilled Membrane Syringes 37
    • 4.3.2 Pen Syringes 40
      • 4.3.2.1 Technical Advances in Pens 41
      • 4.3.2.2 Advantages of Pens 42
      • 4.3.2.3 Pen Types and Styles 42
      • 4.3.2.4 Prefilled Pens 42
      • 4.3.2.5 Reusable Pens 43
      • 4.3.2.6 Device Preparation 43
      • 4.3.2.7 Autopen 44
      • 4.3.2.8 Unifine Pentips 44
    • 4.3.3 Autoject 2 44
  • 4.4 Insulin Syringes 44
  • 4.5 Jet Injectors 48
  • 4.6 Insulin Pens 48
  • 4.7 Uniject™ Injection Device 51
  • 4.8 Microneedle 54
  • 4.9 Needle-Free Injection 54
    • 4.9.1 Hypospray 55
  • 4.10 Glass Prefillable Syringes 55
  • 4.11 Retractable Syringe 55
  • 4.12 Ultrasafe Passive Delivery Systems 56
  • 4.13 Ultrasmall Syringes and Microsyringes 57
  • 4.14 Tip-Lok® Syringes 57
  • 4.15 Product Profiles 57
    • 4.15.1 Gettig Guard™ 57
    • 4.15.2 Inviro SNAP! ® 57
    • 4.15.3 Maxxon Safety Syringe 58
    • 4.15.4 Monoject Magellan™ 58
    • 4.15.5 Needle-Pro 58
    • 4.15.6 Point-Lok® 59
    • 4.15.7 SafetyGlide™ 59
  • 4.16 SC Injection Technology 59
  
  
• 5. Business Trends 61
  • 5.1 Market Drivers 61
  • 5.2 Market Prospects 64
  • 5.3 Marketing and Distribution 65
  • 5.4 Competitive Landscape 65
  • 5.5 Business Developments 67
  • 5.6 Acquisitions and Partnerships 67
  • 5.7 Key Players 68
    • 5.7.1 Kendall 68
    • 5.7.2 Becton Dickinson 68
    • 5.7.3 C.R. Bard 69
    • 5.7.4 International Medication Systems 70
    • 5.7.5 Terumo Medical Corporation 70
    
    
• 6. Future Technologies 71
  • 6.1 Thermostable Vaccines and Vaccine Vial Monitors 71
  • 6.2 Sugar Glass 71
  • 6.3 Issues in Technology Transfer for AD Syringes 73
  
  
• 7. Regulatory Measures 75
  • 7.1 Safety Syringes in Europe 75
  • 7.2 Safety Syringe Regulations and Recommendations 75
  • 7.3 Reimbursement Outlook for Injectables 76
  
  
• 8. Corporate Profiles 77


• 9. Corporate Directory 112

 

Appendix 1: FDA-Approved Syringe Manufacturers 123

Appendix 2: NAPPSI Primary and Secondary Prevention: Needlestick Safety Device List 130

Appendix 3: Ambulatory Care Services OSHA/Safety Device Listing 134

INDEX OF FIGURES

Figure 1. U.S. Safety Needle and Syringe Market 19

Figure 2. Strategy of the "Sugar Project" 73

INDEX OF TABLES

Table 1: Global Market for Injection Devices 8

Table 2: Global Market for Needles and Syringes 8

Table 3: Global Market for Injection Devices by Category, 2004 16

Table 4: Worldwide Dollar Market for Needles and Syringes 17

Table 5: Worldwide Unit Market for Needles and Syringes 17

Table 6: U.S. Dollar Market for Needles and Syringes 18

Table 7: Worldwide Disposable Needle and Syringe Market, 1998-2006 19

Table 8: Worldwide Market for Disposable Needles and Syringes by Region 2004 19

Table 9: Worldwide Safety Syringe Unit Sales, 1998-2006 20

Table 10: Worldwide Safety Syringe Dollar Volume, 1998-2006 20

Table 11: Share of Worldwide Safety Syringes Market by Competitor 20

Table 12: Share of Worldwide Market for Safety Syringes by Region 20

Table 13: Worldwide Prefilled Syringe Unit Sales, 1998-2006 21

Table 14: Worldwide Prefilled Syringe Dollar Volume, 1998-2006 21

Table 15: Share of Worldwide Prefilled Syringe Market by Competitor 21

Table 16: Share of Worldwide Market for Prefilled Syringes by Region 21

Table 17: Worldwide Insulin Injector Pen Dollar Volume, 1998-2006 22

Table 18: Worldwide Market for Needle-Free Injectable Drug Delivery Systems 23

Table 19: Worldwide Needleless Injector Dollar Volume, 1998-2006 23

Table 20: Worldwide Vaccination Injector Unit Sales, 1998-2006 23

Table 21: Share of Worldwide Market for Vaccination Injectors by Region 24

Table 22: Worldwide Vaccination Injector Dollar Volume, 1998-2006 24

Table 23: Share of Worldwide Vaccination Injector Market by Competitor 24

Table 24: Summary of Strengths and Weaknesses of Available Syringes 29

Table 25: Annual Change Per Capita in Healthcare Spending and Gross Domestic Product, 1994-2004 33

Table 26: Injection Data Using Soloshot and Disposable Syringes 35

Table 27: Summary Data for Doses by Soloshot and Disposable Syringes 35

Table 28: Wastage Analysis (Per Vial Used) 36

Table 29: Important Injectable Drug Therapies Using Prefilled Devices 37

Table 30: Regionwise Market of Prefilled Syringes 39

Table 31: Worldwide Prefilled Syringe Unit Sales, 1998-2006 40

Table 32: Worldwide Prefilled Syringe Dollar Volume, 1998-2004 40

Table 33: Insulin Delivery Systems Percent Retail Market Share 45

Table 34: Insulin Delivery Systems Percent Retail Market Share by Company 45

Table 35: Commonly-Available Insulin Syringes 46

Table 36: Features of Available Insulin Pumps 47

Table 37: Features of Available Jet Injectors 48

Table 38: Currently-Available Insulin Delivery Pens 50

Table 39: Summary of Clinical and Field Experience with the Uniject Device 52

Table 40: Comparative System Costs of Hepatitis B Presentations and Injection Devices 64

Table 41: Novo Nordisk Global Sales 102

 

Other users found this report page using the following search terms: Syringe prefilled syringes insulin injector pens needleless blood collection market safety syringe share markets syringes magellan monodose prefillable usa

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.